Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54,800
Closed -$6.87M 1628
2025
Q4
$6.87M Buy
+54,800
New +$6.98M 0.06% 210
2024
Q4
Sell
-7,700
Closed -$878K 1604
2024
Q3
$878K Sell
7,700
-13,800
-64% -$1.51M 0.02% 927
2024
Q2
$2.23M Buy
+21,500
New +$2.28M 0.04% 359
2024
Q1
Sell
-1,500
Closed -$165K 1716
2023
Q4
$165K Sell
1,500
-4,100
-73% -$410K ﹤0.01% 1477
2023
Q3
$542K Buy
+5,600
New +$588K 0.01% 924
2020
Q1
Sell
-70,000
Closed -$6.08M 581
2019
Q4
$6.08M Hold
70,000
0.3% 74
2019
Q3
$5.86M Buy
70,000
+58,800
+525% +$5M 0.36% 52
2019
Q2
$942K Buy
+11,200
New +$882K 0.06% 218

Other funds holding ABT

Centiva Capital's ABT Position: Q1 2026 in Review

Centiva Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 13,903 shares — an estimated $1.74M sold.

Centiva Capital first reported a position in ABT in Q3 2019 and held it in 17 quarters. The position peaked at $4.42M in Q2 2024. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Centiva Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 13,903 Abbott shares in Q1 2026, an estimated $1.74M.
  • Centiva Capital first reported a position in Abbott in Q3 2019 and held it in 17 quarters.
  • Centiva Capital's Abbott position peaked at $4.42M in Q2 2024.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.